4-氨基吡啶促进小鼠胫骨骨折愈合中BMP2表达并加速愈合
该研究在小鼠胫骨中段骨折模型中给予4-氨基吡啶(4-AP,1.6 mg/kg/天,腹腔注射)或生理盐水,21天后Micro-CT显示4-AP组骨密度、骨体积分数、骨小梁数目和厚度均优于生理盐水组,三点弯曲试验刚度更高;体外实验显示4-AP上调人骨髓间充质干细胞和人成骨细胞中BMP2及成骨基因表达,并增强迁移、增殖、胶原沉积和基质矿化。
要点
- 4-AP显著上调hBMSCs和hOBs中BMP2基因和蛋白表达。
- 小鼠胫骨骨折后21天,4-AP组骨密度687.12 vs 生理盐水组488.29 mg羟基磷灰石/cm³(p≤0.0021)。
- 4-AP组三点弯曲刚度27.93 vs 生理盐水组14.30 N/mm(p≤0.05)。
核心结论
- 4-AP提高了小鼠胫骨骨折后的愈合速率、生物力学性能和内源性BMP2表达。
研究设计与样本
- 动物实验:10周龄C57BL/6J雄性小鼠(22至28 g)行胫骨中段骨折后,分为4-AP组(1.6 mg/kg/天,腹腔注射)和生理盐水组(0.1 mL/只/天,腹腔注射),第21天取材行Micro-CT、三点弯曲试验和组织形态学分析。
- 体外实验:评估4-AP对人骨髓间充质干细胞(hBMSC)和人成骨细胞(hOB)活力、迁移、增殖、胶原沉积、基质矿化及成骨基因/蛋白表达的影响。
主要发现
- 4-AP显著上调hBMSCs和hOBs中BMP2基因和蛋白表达以及RUNX2、OSX、BSP、OCN和OPN基因表达。
- 4-AP显著增强成骨细胞迁移和增殖、胶原沉积和基质矿化。
- Micro-CT显示4-AP组 vs 生理盐水组:骨密度687.12 vs 488.29 mg羟基磷灰石/cm³(p≤0.0021);骨体积/组织体积0.87 vs 0.72(p≤0.05);骨小梁数目7.50 vs 5.78/mm(p≤0.05);骨小梁厚度0.08 vs 0.06 mm(p≤0.05)。
- 三点弯曲试验显示4-AP组刚度27.93 vs 生理盐水组14.30 N/mm(p≤0.05)。
- 4-AP还增加了愈合骨痂中内源性BMP2表达和基质成分。
关键数值与推荐
- 4-AP剂量为1.6 mg/kg/天,腹腔注射;生理盐水剂量为0.1 mL/只/天,腹腔注射。
- Micro-CT骨密度:4-AP组687.12 vs 生理盐水组488.29 mg羟基磷灰石/cm³(p≤0.0021)。
- 骨体积/组织体积:4-AP组0.87 vs 生理盐水组0.72(p≤0.05)。
- 骨小梁数目:4-AP组7.50 vs 生理盐水组5.78/mm(p≤0.05);骨小梁厚度:4-AP组0.08 vs 生理盐水组0.06 mm(p≤0.05)。
- 三点弯曲刚度:4-AP组27.93 vs 生理盐水组14.30 N/mm(p≤0.05)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 证据等级为预后Level III。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Delayed bone healing is common in orthopaedic clinical care. Agents that alter cell function to enhance healing would change treatment paradigms. 4-aminopyridine (4-AP) is a U.S. Food and Drug Administration (FDA)-approved drug shown to improve walking in patients with chronic neurological disorders. We recently showed 4-AP's positive effects in the setting of nerve, wound, and even combined multi-tissue limb injury. Here, we directly investigated the effects of 4-AP on bone fracture healing, where differentiation of mesenchymal stem cells into osteoblasts is crucial. METHODS: All animal experiments conformed to the protocols approved by the Institutional Animal Care and Use Committee at the University of Arizona and Pennsylvania State University. Ten-week-old C57BL/6J male mice (22 to 28 g), following midshaft tibial fracture, were assigned to 4-AP (1.6 mg/kg/day, intraperitoneal [IP]) and saline solution (0.1 mL/mouse/day, IP) treatment groups. Tibiae were harvested on day 21 for micro-computed tomography (CT), 3-point bending tests, and histomorphological analyses. 4-AP's effect on human bone marrow mesenchymal stem cell (hBMSC) and human osteoblast (hOB) cell viability, migration, and proliferation; collagen deposition; matrix mineralization; and bone-forming gene/protein expression analyses was assessed. RESULTS: 4-AP significantly upregulated BMP2 gene and protein expression and gene expression of RUNX2, OSX, BSP, OCN, and OPN in hBMSCs and hOBs. 4-AP significantly enhanced osteoblast migration and proliferation, collagen deposition, and matrix mineralization. Radiographic and micro-CT imaging confirmed 4-AP's benefit versus saline solution treatment in mouse tibial fracture healing (bone mineral density, 687.12 versus 488.29 mg hydroxyapatite/cm 3 [p ≤ 0.0021]; bone volume/tissue volume, 0.87 versus 0.72 [p ≤ 0.05]; trabecular number, 7.50 versus 5.78/mm [p ≤ 0.05]; and trabecular thickness, 0.08 versus 0.06 mm [p ≤ 0.05]). Three-point bending tests demonstrated 4-AP's improvement of tibial fracture biomechanical properties versus saline solution (stiffness, 27.93 versus 14.30 N/mm; p ≤ 0.05). 4-AP also increased endogenous BMP2 expression and matrix components in healing callus. CONCLUSIONS: 4-AP increased the healing rate, biomechanical properties, and endogenous BMP2 expression of tibiae following fracture. LEVEL OF EVIDENCE: Prognostic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Ellur G, Govindappa PK, Subrahmanian S, et al. 4-Aminopyridine Promotes BMP2 Expression and Accelerates Tibial Fracture Healing in Mice. J Bone Joint Surg Am. 2025. PMID: 40120116. doi:10.2106/JBJS.24.00311
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。